Myeloma bone disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Skeletal complications are a major problem for patients affected by cancers which metastasize to or grow primarily within bone [1]. As advancements in chemotherapeutic regimens have led to progressive lifespan extension in patients with malignancies, efforts to limit both cancer-associated and treatment-associated skeletal complications have become increasingly important for the provision of optimal patient care.

Original languageEnglish (US)
Title of host publicationMultiple Myeloma: Diagnosis and Treatment
PublisherSpringer New York
Pages211-224
Number of pages14
ISBN (Print)9781461485209, 9781461485193
DOIs
StatePublished - Jan 1 2014

Fingerprint

Bone Diseases
Second Primary Neoplasms
Neoplasms
Patient Care
Bone and Bones

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Drake, M. M. (2014). Myeloma bone disease. In Multiple Myeloma: Diagnosis and Treatment (pp. 211-224). Springer New York. https://doi.org/10.1007/978-1-4614-8520-9_17

Myeloma bone disease. / Drake, Matthew M.

Multiple Myeloma: Diagnosis and Treatment. Springer New York, 2014. p. 211-224.

Research output: Chapter in Book/Report/Conference proceedingChapter

Drake, MM 2014, Myeloma bone disease. in Multiple Myeloma: Diagnosis and Treatment. Springer New York, pp. 211-224. https://doi.org/10.1007/978-1-4614-8520-9_17
Drake MM. Myeloma bone disease. In Multiple Myeloma: Diagnosis and Treatment. Springer New York. 2014. p. 211-224 https://doi.org/10.1007/978-1-4614-8520-9_17
Drake, Matthew M. / Myeloma bone disease. Multiple Myeloma: Diagnosis and Treatment. Springer New York, 2014. pp. 211-224
@inbook{94d8759c84fd4d3b9eec9d4cfe6a5107,
title = "Myeloma bone disease",
abstract = "Skeletal complications are a major problem for patients affected by cancers which metastasize to or grow primarily within bone [1]. As advancements in chemotherapeutic regimens have led to progressive lifespan extension in patients with malignancies, efforts to limit both cancer-associated and treatment-associated skeletal complications have become increasingly important for the provision of optimal patient care.",
author = "Drake, {Matthew M}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-8520-9_17",
language = "English (US)",
isbn = "9781461485209",
pages = "211--224",
booktitle = "Multiple Myeloma: Diagnosis and Treatment",
publisher = "Springer New York",

}

TY - CHAP

T1 - Myeloma bone disease

AU - Drake, Matthew M

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Skeletal complications are a major problem for patients affected by cancers which metastasize to or grow primarily within bone [1]. As advancements in chemotherapeutic regimens have led to progressive lifespan extension in patients with malignancies, efforts to limit both cancer-associated and treatment-associated skeletal complications have become increasingly important for the provision of optimal patient care.

AB - Skeletal complications are a major problem for patients affected by cancers which metastasize to or grow primarily within bone [1]. As advancements in chemotherapeutic regimens have led to progressive lifespan extension in patients with malignancies, efforts to limit both cancer-associated and treatment-associated skeletal complications have become increasingly important for the provision of optimal patient care.

UR - http://www.scopus.com/inward/record.url?scp=84956560566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956560566&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-8520-9_17

DO - 10.1007/978-1-4614-8520-9_17

M3 - Chapter

AN - SCOPUS:84956560566

SN - 9781461485209

SN - 9781461485193

SP - 211

EP - 224

BT - Multiple Myeloma: Diagnosis and Treatment

PB - Springer New York

ER -